Pericentromeric Satellite III transcripts induce etoposide resistance

Cell Death Dis. 2021 May 24;12(6):530. doi: 10.1038/s41419-021-03810-9.

Abstract

Non-coding RNA from pericentromeric satellite repeats are involved in stress-dependent splicing processes, maintenance of heterochromatin, and are required to protect genome stability. Here we show that the long non-coding satellite III RNA (SatIII) generates resistance against the topoisomerase IIa (TOP2A) inhibitor etoposide in lung cancer. Because heat shock conditions (HS) protect cells against the toxicity of etoposide, and SatIII is significantly induced under HS, we hypothesized that the protective effect could be traced back to SatIII. Using genome methylation profiles of patient-derived xenograft mouse models we show that the epigenetic modification of the SatIII DNA locus and the resulting SatIII expression predict chemotherapy resistance. In response to stress, SatIII recruits TOP2A to nuclear stress bodies, which protects TOP2A from a complex formation with etoposide and results in decreased DNA damage after treatment. We show that BRD4 inhibitors reduce the expression of SatIII, restoring etoposide sensitivity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Cell Cycle Proteins / antagonists & inhibitors
  • Centromere / genetics
  • Centromere / metabolism
  • DNA Methylation / physiology
  • DNA Topoisomerases, Type II / drug effects
  • DNA Topoisomerases, Type II / genetics
  • DNA Topoisomerases, Type II / metabolism
  • Drug Resistance, Neoplasm / drug effects
  • Drug Resistance, Neoplasm / genetics*
  • Etoposide / therapeutic use*
  • Gene Expression Regulation, Neoplastic / drug effects
  • HEK293 Cells
  • HeLa Cells
  • Humans
  • Male
  • Mice
  • Mice, Inbred NOD
  • Mice, SCID
  • Poly-ADP-Ribose Binding Proteins / drug effects
  • Poly-ADP-Ribose Binding Proteins / genetics
  • Poly-ADP-Ribose Binding Proteins / metabolism
  • RNA, Long Noncoding / genetics
  • RNA, Long Noncoding / physiology*
  • Transcription Factors / antagonists & inhibitors
  • Tumor Cells, Cultured
  • Xenograft Model Antitumor Assays

Substances

  • Antineoplastic Agents
  • BRD4 protein, human
  • Cell Cycle Proteins
  • Poly-ADP-Ribose Binding Proteins
  • RNA, Long Noncoding
  • Transcription Factors
  • Etoposide
  • DNA Topoisomerases, Type II
  • TOP2A protein, human